Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Tax Payment
Common Stock
2025-03-23$64.26/sh−17,455$1,121,658→ 468,179 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.